Stock listing
NASDAQ:SILO Silo Pharma, Inc. Stock
Home listing (NASDAQ) of Silo Pharma, Inc.
Follow Silo Pharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SILO
$1.71 USD -0.18 (-9.5%)
Close on Nov 20, 2026
- Day range
- $1.67 – $1.82 USDNov 20, 2026
- Volume
- 41,635 sharesNov 20, 2026
- Market cap
- $3.77M USDAt the close on Nov 20, 2026 · price × 2.20M shares outstanding
- 52-week range
- $1.10 – $10.42 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $106,856 USDMedian day 28,800 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SILO · Home | $1.71 USD | -0.18 (-9.5%) | 41,635 | $1.78 | $1.82 | $1.67 | $1.89 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SILO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.71 | -0.18 | -9.5% | $1.78 | $1.82 | $1.67 | 41,635 | |
| $1.89 | +0.18 | +10.5% | $1.765 | $1.91 | $1.64 | 49,806 | |
| $1.71 | +0.135 | +8.6% | $1.61 | $1.72 | $1.53 | 32,759 | |
| $1.575 | -0.265 | -14.4% | $1.76 | $1.839 | $1.485 | 69,529 | |
| $1.84 | -0.07 | -3.7% | $1.89 | $1.92 | $1.76 | 48,848 | |
| $1.91 | +0.068 | +3.7% | $1.90 | $1.95 | $1.795 | 65,040 | |
| $1.842 | +0.052 | +2.9% | $1.84 | $1.976 | $1.72 | 147,476 | |
| $1.79 | +0.16 | +9.8% | $1.67 | $1.839 | $1.58 | 134,542 | |
| $1.63 | +0.30 | +22.6% | $1.385 | $1.71 | $1.385 | 176,035 | |
| $1.33 | +0.04 | +3.1% | $1.26 | $1.365 | $1.25 | 21,170 | |
| $1.29 | -0.04 | -3.0% | $1.219 | $1.40 | $1.185 | 37,725 | |
| $1.33 | +0.05 | +3.9% | $1.212 | $1.34 | $1.212 | 18,311 | |
| $1.28 | +0.07 | +5.8% | $1.21 | $1.291 | $1.21 | 21,275 | |
| $1.21 | -0.02 | -1.6% | $1.244 | $1.285 | $1.206 | 11,578 | |
| $1.23 | -0.02 | -1.6% | $1.24 | $1.25 | $1.198 | 12,039 | |
| $1.25 | -0.09 | -6.7% | $1.31 | $1.32 | $1.25 | 15,465 | |
| $1.34 | +0.05 | +3.9% | $1.26 | $1.377 | $1.26 | 11,478 | |
| $1.29 | +0.13 | +11.2% | $1.15 | $1.29 | $1.14 | 21,697 | |
| $1.16 | -0.02 | -1.7% | $1.142 | $1.175 | $1.142 | 6,225 | |
| $1.18 | 0.00 | 0.0% | $1.17 | $1.195 | $1.17 | 6,600 | |
| $1.18 | -0.02 | -1.7% | $1.20 | $1.22 | $1.17 | 23,700 | |
| $1.20 | 0.00 | 0.0% | $1.19 | $1.232 | $1.183 | 7,200 | |
| $1.20 | +0.07 | +6.2% | $1.151 | $1.21 | $1.149 | 9,500 | |
| $1.13 | -0.05 | -4.2% | $1.20 | $1.205 | $1.13 | 18,900 | |
| $1.18 | -0.02 | -1.7% | $1.22 | $1.23 | $1.17 | 10,200 | |
| $1.20 | 0.00 | 0.0% | $1.20 | $1.235 | $1.15 | 14,100 | |
| $1.20 | -0.02 | -1.6% | $1.22 | $1.26 | $1.20 | 64,800 | |
| $1.22 | -0.27 | -18.1% | $1.41 | $1.43 | $1.10 | 153,900 | |
| $1.49 | +0.02 | +1.4% | $1.47 | $1.49 | $1.42 | 22,200 | |
| $1.47 | +0.02 | +1.4% | $1.44 | $1.48 | $1.395 | 17,000 | |
| $1.45 | +0.01 | +0.7% | $1.43 | $1.451 | $1.37 | 14,300 | |
| $1.44 | -0.01 | -0.7% | $1.43 | $1.46 | $1.41 | 22,400 | |
| $1.45 | -0.04 | -2.7% | $1.50 | $1.50 | $1.40 | 27,600 | |
| $1.49 | +0.032 | +2.2% | $1.35 | $1.51 | $1.30 | 207,900 | |
| $1.458 | -0.042 | -2.8% | $1.50 | $1.57 | $1.45 | 1,152,700 | |
| $1.50 | -0.01 | -0.7% | $1.51 | $1.60 | $1.475 | 44,200 | |
| $1.51 | -0.10 | -6.2% | $1.60 | $1.60 | $1.463 | 205,600 | |
| $1.61 | -0.04 | -2.4% | $1.71 | $1.71 | $1.61 | 29,000 | |
| $1.65 | -0.10 | -5.7% | $1.74 | $1.789 | $1.65 | 22,700 | |
| $1.75 | 0.00 | 0.0% | $1.81 | $1.81 | $1.72 | 20,100 | |
| $1.75 | -0.02 | -1.1% | $1.79 | $1.83 | $1.72 | 24,600 | |
| $1.77 | +0.05 | +2.9% | $1.74 | $1.84 | $1.74 | 44,400 | |
| $1.72 | -0.025 | -1.4% | $1.77 | $1.77 | $1.71 | 42,900 | |
| $1.745 | -0.095 | -5.2% | $1.77 | $1.84 | $1.72 | 64,400 | |
| $1.84 | +0.12 | +7.0% | $1.70 | $1.90 | $1.662 | 282,000 | |
| $1.72 | -0.04 | -2.3% | $1.82 | $1.88 | $1.66 | 51,000 | |
| $1.76 | -0.18 | -9.3% | $1.97 | $1.97 | $1.63 | 80,700 | |
| $1.94 | -0.13 | -6.3% | $2.09 | $2.09 | $1.91 | 40,200 | |
| $2.07 | -0.03 | -1.4% | $2.08 | $2.20 | $2.05 | 28,800 | |
| $2.10 | -0.004 | -0.2% | $2.19 | $2.19 | $2.05 | 36,600 | |
| $2.104 | -0.046 | -2.1% | $2.18 | $2.39 | $2.10 | 19,600 | |
| $2.15 | -0.13 | -5.7% | $2.34 | $2.34 | $2.14 | 39,900 | |
| $2.28 | -0.12 | -5.0% | $2.33 | $2.356 | $2.22 | 20,600 | |
| $2.40 | -0.05 | -2.0% | $2.45 | $2.50 | $2.205 | 35,500 | |
| $2.45 | -0.05 | -2.0% | $2.51 | $2.54 | $2.37 | 15,000 | |
| $2.50 | +0.06 | +2.5% | $2.46 | $2.50 | $2.46 | 5,400 | |
| $2.44 | -0.04 | -1.6% | $2.56 | $2.56 | $2.44 | 7,800 | |
| $2.48 | -0.06 | -2.4% | $2.48 | $2.55 | $2.47 | 22,600 | |
| $2.54 | 0.00 | 0.0% | $2.54 | $2.58 | $2.475 | 18,800 | |
| $2.54 | +0.04 | +1.6% | $2.44 | $2.57 | $2.433 | 18,100 | |
| $2.50 | -0.09 | -3.5% | $2.59 | $2.752 | $2.49 | 38,400 | |
| $2.59 | +0.01 | +0.4% | $2.52 | $2.63 | $2.46 | 56,100 | |
| $2.58 | -0.07 | -2.6% | $2.64 | $2.732 | $2.501 | 45,400 | |
| $2.65 | -0.09 | -3.3% | $2.77 | $2.887 | $2.60 | 63,300 | |
| $2.74 | -0.12 | -4.2% | $2.80 | $2.82 | $2.70 | 32,700 |
Splits
1 split · NASDAQ:SILO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation |
- Ticker
- NASDAQ:SILO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 30, 2026
Silo Pharma's QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
Latest deck · March 2026
Investor Presentation (March 2026)
Investor deck · 18 slides
Latest news
Silo Pharma's QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
Sep 30, 2026
Closed $1.51 (-6.2%) on Sep 30, 2026
Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
Sep 18, 2026
Closed $1.84 (+7.0%) on Sep 18, 2026
Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
Sep 9, 2026
Closed $2.15 (-5.7%) on Sep 9, 2026
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
Aug 18, 2026
Closed $2.86 (-6.8%) on Aug 19, 2026
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
Aug 10, 2026
Closed $3.78 (+1.2%) on Aug 10, 2026
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
Aug 6, 2026
Closed $4.67 (+1.3%) on Aug 6, 2026
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program
Jul 21, 2026
Closed $4.71 (+0.2%) on Jul 21, 2026
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
Jul 14, 2026
Closed $5.13 (-2.8%) on Jul 14, 2026
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jul 10, 2026
Closed $5.70 (-26.3%) on Jul 10, 2026
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
Jul 7, 2026
Closed $5.66 (-9.0%) on Jul 7, 2026
Silo Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 153 in all · newest Sep 30, 2026 · oldest 2020
- Decks
- 6 decks · latest March 2026
Where Silo Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SILO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:SILO | BOATS | United States | USD |
Valuation
Price/book 0.5× against a median of 0.8×: 3rd lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$4.28M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.5×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.23
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Silo Pharma, Inc. · NASDAQ:SILO | US$3.77M | −US$4.28M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.23 |
| Processa Pharmaceuticals, Inc. · NASDAQ:PCSA | US$4.37M | −US$175.8M | n/a | n/a | n/a | n/a | n/a | n/a | 1.60 |
| AdAlta Ltd. · ASX:1AD | US$4.25M | US$3.40M | n/a | n/a | n/a | 17.4× | n/a | 0.0× | n/a |
| Percheron Therapeutics Limited · ASX:PER | US$3.94M | US$1.27M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | n/a |
| Lantern Pharma Inc. · NASDAQ:LTRN | US$3.89M | −US$3.69M | n/a | n/a | n/a | 2.8× | n/a | 0.0× | 2.80 |
| Alzamend Neuro, Inc. · NASDAQ:ALZN | US$3.74M | −US$3.85M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.00 |
| Biotron Limited · ASX:BIT | US$3.69M | US$2.66M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | n/a |
| Reviva Pharmaceuticals Holdings, Inc. · NASDAQ:RVPH | US$3.68M | −US$13.77M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.57 |
| Liminatus Pharma, Inc. · NASDAQ:LIMN | US$3.37M | US$1.80M | n/a | n/a | n/a | 11.2× | n/a | 4.8× | 0.94 |
| Xenetic Biosciences, Inc. · NASDAQ:XBIO | US$3.28M | −US$2.53M | n/a | −0.8× | n/a | 0.7× | −123.7% | 0.0× | 1.46 |
| Aprea Therapeutics, Inc. · NASDAQ:APRE | US$3.25M | −US$34.60M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 0.73 |
| Median of the others | US$3.72M | −US$3.11M | −0.8× | 0.8× | −123.7% | 0.0× | 1.57 |
Team and board
Officers
| Officer | Role |
|---|---|
| Eric Weisblum | CEO |
| James Kuo | Vice President of R&D |
Board
| Director | Role |
|---|---|
| Eric Weisblum | CEO |
| Jeff Pavell D.O. | Member |
| Kevin Muñoz | Board Member |
| Wayne D. Linsley | Board Member |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 13, 2026 | −17.5% |
| Q2 2026 | Aug 13, 2026 | +3.4% |
| Q1 2026 | May 29, 2026 | −21.5% |
| Q3 2025 | Dec 3, 2025 | −0.9% |
| Q2 2025 | Aug 13, 2025 | +2.7% |
| Q1 2025 | May 9, 2025 | +31.3% |
| Q4 2024 | Mar 28, 2025 | −11.4% |
| Q3 2024 | Nov 27, 2024 | +13.6% |
| Q2 2024 | Aug 28, 2024 | −15.5% |
| Q1 2024 | May 29, 2024 | +2.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 25, 2024 · After close | +0.5% |
| Q3 2023 | Nov 13, 2023 · After close | −3.4% |
| Q2 2023 | Aug 12, 2023 · Before open | −2.5% |
| Q1 2023 | May 31, 2023 | +2.6% |
| Q4 2022 | Mar 24, 2023 | −1.5% |
| Q3 2022 | Nov 10, 2022 | +1.9% |
| Q2 2022 | Aug 1, 2022 | −5.8% |
| Q1 2022 | May 13, 2022 | 0.0% |
| Q4 2021 | Mar 28, 2022 | +25.0% |
| Quarter to Sep 30, 2021 | Nov 10, 2021 | −0.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2026) | Investor deck | 18 slides | March 2026 |
| Investor Presentation (March 2025) | Investor deck | 17 slides | Mar 10, 2025 |
| Investor Presentation (March 2025) | Investor deck | 18 slides | March 2025 |
| Investor Presentation (September 2024) | Investor deck | 18 slides | Sep 10, 2024 |
| Investor Presentation (October 2022) | Investor deck | 24 slides | Oct 18, 2022 |
| Investor Presentation (June 2022) | Investor deck | 19 slides | Jun 1, 2022 |
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (or pre-funded warrants) with Series A-3 and Series A-4 warrants Announced: about US$4M · US$6.452 a share · Warrants at US$6.21 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 10, 2026 |
| Registered direct offering of shares of common stock with concurrent unregistered warrants Closed: US$2.5M raised · US$0.875 a share · Warrants at US$0.75 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Oct 1, 2025 |
| Public offering of shares of common stock (or pre-funded warrants) with series A-1 and A-2 warrants Closed: US$2M raised · US$0.6 a share · Warrants at US$0.6 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: General working capital purposes | May 16, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 72.1K | 72.1K | 72.1K | 72.1K | 71.3K | 40.9K | 40.6K | 0 | 847.4K | -669.5K |
| Cost of revenue | 44.3K | 5.84K | 5.84K | 5.84K | 5.00K | 176.1K | 27.4K | 17.6K | ||
| Gross profit | 27.8K | 66.3K | 66.3K | 66.3K | 66.3K | -135.2K | 13.2K | -17.6K | 847.4K | -669.5K |
| Research and development | 2.16M | 2.37M | 845.1K | 1.29M | 693.9K | 26.3K | 63.5K | |||
| Selling, general and administrative | 2.15M | 2.40M | 390.1K | 227.3K | 163.0K | 50.2K | 864.2K | 459.8K | 313.4K | 301.0K |
| Operating income | -4.28M | -4.71M | -3.86M | -3.63M | -2.74M | -2.20M | -930.4K | -594.2K | -490.9K | -393.7K |
| Depreciation and amortization | 11.4K | 6.18K | 90.1K | 72.6K | 108.0K | 578.9K | 61.9K | 17.6K | 17.6K | 393.7K |
| EBITDA | -4.27M | -4.70M | -3.77M | -3.56M | -2.64M | -1.62M | -868.5K | -576.7K | -473.3K | 0 |
| Interest expense | 37.3K | 5.08K | 4.87K | 2.20K | 3.04K | 80 | 0 | 4.22K | 20.5K | 49.8K |
| Income before tax | -4.23M | -4.39M | -3.63M | -3.91M | 4.18M | -2.67M | -1.01M | -969.5K | 356.5K | -1.11M |
| Income tax | 69.6K | 1.16K | 24.9K | 92.3K | 34.8K | -513.9K | -62.9K | |||
| Net income | -4.23M | -4.39M | -3.70M | -3.91M | 3.90M | -3.04M | -1.01M | -969.5K | 356.5K | -1.11M |
| Earnings per share, basic | -0.50 | -1.19 | -1.20 | -1.24 | 0.04 | -0.05 | -0.04 | -0.02 | 0.01 | -16.63 |
| Earnings per share, diluted | -0.50 | -1.19 | -1.20 | 0.04 | -0.05 | -0.04 | -0.02 | 0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.75M | 3.91M | 3.52M | 11.4M | 9.84M | 1.13M | 111.8K | 336.7K | 294.6K | 579.2K |
| Short-term investments | 2.11M | 3.17M | 4.14M | 3.12K | 420.0K | 200 | 9.39K | 228.3K | 1.32M | |
| Receivables | 66.0K | 61.2K | 23.5K | 200.0K | 58.5K | |||||
| Inventory | -61.2K | 33.5K | 156.4K | 27.0K | ||||||
| Current assets | 7.39M | 7.11M | 7.68M | 11.6M | 10.4M | 1.43M | 493.8K | 626.0K | 1.64M | 664.7K |
| Total assets | 7.61M | 7.41M | 7.75M | 11.6M | 10.5M | 1.43M | 493.8K | 855.4K | 1.64M | 1.30M |
| Accounts payable | 578.1K | 1.58M | 703.5K | 364.2K | 417.9K | 127.1K | 54.9K | 25.6K | 38.3K | 53.1K |
| Current liabilities | 650.2K | 1.66M | 775.6K | 436.3K | 490.0K | 141.7K | 116.7K | 48.0K | 38.3K | 53.1K |
| Long-term debt | 4.25K | |||||||||
| Total debt | 18.9K | 61.9K | 22.3K | |||||||
| Total liabilities | 1.30M | 2.38M | 1.57M | 1.30M | 1.43M | 146.0K | 116.7K | 448.0K | 438.3K | 453.1K |
| Shareholders' equity | 6.31M | 5.03M | 6.18M | 10.3M | 9.06M | 1.28M | -22.9K | 407.4K | 1.20M | 846.5K |
| Shares outstanding | 887.9K | 4.48M | 2.91M | 3.16M | 1.97M | 85.1M | 23.6M | 23.4M | 50.1M | 66.9K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4.66M | -3.83M | -3.22M | -3.50M | -2.28M | -1.16M | -794.3K | 272.6K | -284.6K | -143.6K |
| Capital spending | -574.9K | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | -4.66M | -3.83M | -3.22M | -3.50M | -2.28M | -1.16M | -794.3K | 272.6K | -284.6K | -143.6K |
| Cash from investing | 644.0K | 973.8K | -4.15M | 86.7K | 7.19M | 39.0K | 186.7K | -250.0K | 157.6K | 344.5K |
| Cash from financing | 4.86M | 3.24M | -471.1K | 4.94M | 3.79M | 2.13M | 382.7K | 19.5K | 19.5K | 0 |
| Dividends paid | -2.18K | |||||||||
| Share buybacks | 0 | -173.1K | -471.1K | 0 | 0 | -2.87K | ||||
| Change in cash | 842.9K | 381.5K | -7.84M | 1.53M | 8.71M | 1.02M | -224.9K | 42.1K | -284.6K | -143.6K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| S-3 · Registration statement | Nov 18, 2026 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 10, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Nov 6, 2026 | Material contract | SEC |
| 8-K · Current report | Oct 14, 2026 | Material contract | SEC |
| 8-K · Current report | Oct 2, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 19, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 17, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2026 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Aug 7, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Aug 6, 2026 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Jul 31, 2026 | Offer document | SEC |
| S-3 · Registration statement | Jul 24, 2026 | Offer document | SEC |
| D | Jul 14, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 10, 2026 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 8, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Jun 30, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jun 30, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jun 30, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 18, 2026 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Jun 18, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 3, 2026 | Current report | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
| 424B3 · Prospectus | Apr 16, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Apr 16, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Apr 14, 2026 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Apr 14, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Apr 14, 2026 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Apr 10, 2026 | Offer document | SEC |
| 8-K · Current report | Apr 2, 2026 | Material contract | SEC |
| 10-K · Annual report | Mar 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 23, 2026 | Financing | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Dec 29, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 16, 2025 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Nov 28, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Nov 26, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 7, 2025 | Big-stake notice | SEC |
| S-1 · Registration statement | Oct 28, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 24, 2025 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 3, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 1, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Oct 1, 2025 | Offer document | SEC |
| DEFA14A · Additional proxy material | Sep 5, 2025 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Sep 5, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Sep 5, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Aug 25, 2025 | Meeting notice | SEC |
| 424B5 · Prospectus | Aug 18, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Aug 5, 2025 | Current report | SEC |
| 8-K · Current report | Jul 29, 2025 | Material contract | SEC |
| 8-K · Current report | Jul 10, 2025 | Material contract | SEC |
| 8-K · Current report | Jul 3, 2025 | Current report | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | May 21, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 16, 2025 | Material contract | SEC |
| 424B4 · Prospectus | May 16, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 16, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 12, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 9, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | May 9, 2025 | Quarterly report | SEC |
| CORRESP · Letter to the SEC | Apr 30, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Apr 29, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Apr 28, 2025 | Other filings | SEC |
| S-1 · Registration statement | Apr 25, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 17, 2025 | Other filings | SEC |
| DRS · Draft registration statement | Apr 11, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Apr 4, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Apr 4, 2025 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Mar 28, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 28, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 10, 2025 | Current report | SEC |
| 8-K · Current report | Mar 7, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 2, 2025 | Current report | SEC |
| 8-K · Current report | Dec 20, 2024 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 22, 2024 | Insider trade | SEC |
| DEFR14A | Nov 15, 2024 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Nov 8, 2024 | Meeting notice | SEC |
| 8-K · Current report | Nov 8, 2024 | Current report | SEC |
| ARS · Annual report to shareholders | Sep 18, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Sep 18, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 18, 2024 | Meeting notice | SEC |
| 8-K · Current report | Sep 10, 2024 | Current report | SEC |
| 424B3 · Prospectus | Sep 4, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 4, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 29, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 28, 2024 | Other filings | SEC |
| S-1 · Registration statement | Aug 21, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| D | Aug 2, 2024 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Jul 31, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Jul 30, 2024 | Offer document | SEC |
| SC 13G · Big-stake notice | Jul 26, 2024 | Big-stake notice | SEC |
| CORRESP · Letter to the SEC | Jul 26, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jul 25, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 22, 2024 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Jul 22, 2024 | Other filings | SEC |
| 424B5 · Prospectus | Jul 22, 2024 | Offer document | SEC |
| S-1 · Registration statement | Jul 17, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 8, 2024 | Material contract | SEC |
| 8-K · Current report | Jun 27, 2024 | Material contract | SEC |
| SC 13G · Big-stake notice | Jun 13, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| D | Jun 11, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 6, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Jun 6, 2024 | Offer document | SEC |
| 8-K · Current report | Jun 4, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 13, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 8-K · Current report | Apr 5, 2024 | Current report | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| 10-K · Annual report | Mar 25, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 1, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Jan 31, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 26, 2024 | Other filings | SEC |
| S-3/A · Registration statement, amended | Jan 25, 2024 | Offer document | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 25, 2024 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Jan 25, 2024 | Other filings | SEC |
| S-3 · Registration statement | Jan 23, 2024 | Offer document | SEC |
| 8-K/A · Current report, amended | Jan 11, 2024 | Current report | SEC |
| 8-K · Current report | Jan 9, 2024 | Current report | SEC |
| 4 · Change in ownership | Dec 21, 2023 | Insider trade | SEC |
| 8-K12B | Dec 20, 2023 | Other filings | SEC |
| 4 · Change in ownership | Dec 18, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 11, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 7, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 5, 2023 | Current report | SEC |
| 8-K · Current report | Dec 4, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Nov 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Oct 23, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 23, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 10, 2023 | Meeting notice | SEC |
| 8-K · Current report | Aug 31, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 29, 2023 | Current report | SEC |
| 4 · Change in ownership | May 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 8-K · Current report | Mar 27, 2023 | Current report | SEC |
| 10-K · Annual report | Mar 24, 2023 | Annual report | SEC |
| 8-K · Current report | Feb 15, 2023 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 3, 2023 | Current report | SEC |
| 8-K · Current report | Jan 31, 2023 | Current report | SEC |
| 8-K · Current report | Jan 20, 2023 | Current report | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2022 | Insider trade | SEC |
| 8-K · Current report | Dec 1, 2022 | Current report | SEC |
| SC 13G · Big-stake notice | Nov 15, 2022 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 10, 2022 | Quarterly report | SEC |
| 8-K · Current report | Oct 18, 2022 | Material contract | SEC |
| 3 · Initial statement of ownership | Oct 4, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 4, 2022 | Insider trade | SEC |
| 8-K · Current report | Sep 30, 2022 | Material contract | SEC |
| 424B4 · Prospectus | Sep 28, 2022 | Offer document | SEC |
| CERT · Exchange's certificate of listing | Sep 27, 2022 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Sep 27, 2022 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Sep 26, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 22, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 22, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Sep 20, 2022 | Offer document | SEC |
| 8-K · Current report | Sep 15, 2022 | Current report | SEC |
| S-1/A · Registration statement, amended | Sep 8, 2022 | Offer document | SEC |
| S-1/A · Registration statement, amended | Aug 26, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 1, 2022 | Quarterly report | SEC |
| S-1/A · Registration statement, amended | Jul 22, 2022 | Offer document | SEC |
| 4 · Change in ownership | Jun 21, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | May 13, 2022 | Quarterly report | SEC |
| 10-K · Annual report | Mar 28, 2022 | Annual report | SEC |
| 8-K · Current report | Mar 11, 2022 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Mar 7, 2022 | Meeting notice | SEC |
| 8-K · Current report | Mar 7, 2022 | Current report | SEC |
| DEF 14A · Proxy statement | Feb 14, 2022 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Feb 2, 2022 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Jan 5, 2022 | Insider trade | SEC |
This page holds 200 of 383 filings. Open Filings
Cap table
Built by 6ix from Silo Pharma, Inc.’s releases · as of Jul 10, 2026
- Common shares
- 2,203,250
- Fully diluted
- 2,203,250
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 2,203,250 |
Warrants and options
| Lot |
|---|
| Warrants · US$0.75 · expire about Oct 2030 |
| Warrants · US$0.60 · expire about May 2030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,203,250 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Leonard M Schiller Other companies: Creatd Inc. (Director · Feb 5, 2016 – Dec 18, 2020 · Past); Milestone Scientific, Inc. (Director · Jun 5, 2008 – Jun 13, 2022 · Past) | Director · Jul 30, 2014 – Jan 1, 2015 · Past |
| Wayne D. Linsley Other companies: Myseum.AI, Inc. (Director · Since at least Jan 14, 2025); Hoth Therapeutics, Inc. (Director · Jul 17, 2023 – Aug 19, 2024 · Past) | Board Member · Since at least May 23, 2025 |
| Daniel E Ryweck | Chief Financial Officer · Since at least May 23, 2025 |
| Donald Ptalis | CFO, Director · Jan 2, 2013 – Jan 2, 2013 · Past |
| Eric Weisblum | Chief Executive Officer, Director · Since at least Nov 16, 2023 |
| James Kuo | Vice President of R&D · Since at least Nov 5, 2026 |
| Jeff Pavell D.O. | Member · Since at least Nov 4, 2026 |
| Kevin Muñoz | Board Member · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Silo Pharma, Inc.